(Q31869703)

English

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1 reference

based on heuristic

inferred from title

hypertriglyceridemia

1 reference

based on heuristic

inferred from title

author name string

de Man FH

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

de Beer F

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

van der Laarse A

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Jansen H

4

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Leuven JA

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Souverijn JH

6

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Vroom TF

7

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Schoormans SC

8

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Fruchart JC

9

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Havekes LM

10

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Smelt AH

11

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

153

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

363-371

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Transport of Very Low Density Lipoprotein Triglycerides in Varying Degrees of Obesity and Hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogenous hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Evidence for genetic control of triglyceride removal

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Separation of plasma lipoproteins by density-gradient ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

Plasma triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900409-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(00)00409-3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31869703&oldid=1910668820"